Related Experiment Video
Updated: Oct 29, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Synuclein in neurodegeneration.
1Neurochemistry Laboratory, 1st Department of Neurology and Movement Disorders, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece; Neuroscience Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Alpha-Synuclein (α-Syn) dysfunction is implicated in neurodegenerative disorders like Parkinson's disease. This review explores α-Syn's role in these conditions from multiple scientific viewpoints.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Neurodegenerative diseases involve progressive neuronal loss with often unknown causes.
- Synucleins are neuronal proteins, with alpha-Synuclein (α-Syn) linked to several neurodegenerative disorders.
Purpose of the Study:
- To review the role of α-Synuclein (α-Syn) dysfunction in neurodegeneration.
- To assess α-Syn's involvement in α-synucleinopathies from biochemical, genetic, and neuroimaging perspectives.
Main Methods:
- Literature review focusing on α-Synuclein (α-Syn).
- Analysis of biochemical, genetic, and neuroimaging data related to α-synucleinopathies.
Main Results:
- α-Synuclein (α-Syn) is a key protein implicated in Parkinson's disease, dementia with Lewy bodies, and other α-synucleinopathies.
- Evidence from biochemical, genetic, and neuroimaging studies supports α-Syn's role in disease pathogenesis.
Conclusions:
- Dysfunctional α-Synuclein (α-Syn) is central to the pathogenesis of α-synucleinopathies.
- Further research into α-Syn's multifaceted role is crucial for understanding and treating these neurodegenerative diseases.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

